New Data at DDW 2025 Further Demonstrates the TissueCypher Test’s Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer
Additionally, an expert physician panel convened by EndoscopyNow will host a product…
Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe…
CGTN: How China contributes to global poverty reduction, drives modernization with developing nations
BEIJING, Nov. 19, 2024 /PRNewswire/ -- John Kimani, an expert from the Kenya…
CGTN: How China contributes to global poverty reduction, drives modernization with developing nations
BEIJING, Nov. 19, 2024 /PRNewswire/ -- John Kimani, an expert from the Kenya…